CAI fundamentals
An in-depth look to Caris Life Sciences, Inc. operating, investing, and financing activities
CAI free cash flow for Q1 25 is -34.03 M USD. For 2024, CAI free cash flow was -253.64 M USD and operating cash flow was -245.2 M USD.
Q1 '24
Q1 '25
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '24
Q1 '25
TTM